SENNA-PLUS 50 mg/1
Sennosides and Docusate Sodium · TABLET · Geri-Care Pharmaceutical Corp
No Recall History
Plain English
SENNA-PLUS is a tablet containing sennosides and docusate sodium at 50 mg/1, taken oral. Manufactured by Geri-Care Pharmaceutical Corp.
Key Facts
- Brand Name
- SENNA-PLUS
- Generic Name
- Sennosides and Docusate Sodium
- NDC Code (Product)
57896-555- Manufacturer
- Geri-Care Pharmaceutical Corp
- Strength
- 50 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- 505G(a)(3)
- Marketing Start
- 05/01/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is SENNA-PLUS used for?
SENNA-PLUS contains Sennosides and Docusate Sodium. It is a tablet taken oral. Consult your doctor for specific uses.
Is SENNA-PLUS a controlled substance?
SENNA-PLUS is not classified as a controlled substance by the DEA.
What is the generic name for SENNA-PLUS?
The generic name for SENNA-PLUS is Sennosides and Docusate Sodium. There are 7 other brand versions of Sennosides and Docusate Sodium.
What is the NDC code for SENNA-PLUS 50 mg/1?
The NDC (National Drug Code) for SENNA-PLUS 50 mg/1 is 57896-555, listed by Geri-Care Pharmaceutical Corp.